Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D00TLM
|
||||
Former ID |
DNC011099
|
||||
Drug Name |
PRUVANSERIN
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Sleep disorders [ICD9: 307.4, 327, 780.5; ICD10:F51, G47] | Phase 2 | [521764] | ||
Structure |
Download2D MOL |
||||
Formula |
C22H21FN4O
|
||||
Canonical SMILES |
C1CN(CCN1CCC2=CC=C(C=C2)F)C(=O)C3=CC=CC4=C3NC=C4C#N
|
||||
InChI |
1S/C22H21FN4O/c23-18-6-4-16(5-7-18)8-9-26-10-12-27(13-11-26)22(28)20-3-1-2-19-17(14-24)15-25-21(19)20/h1-7,15,25H,8-13H2
|
||||
InChIKey |
AQRLDDAFYYAIJP-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 443144-26-1
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | 5-hydroxytryptamine 2A receptor | Target Info | Modulator | [552847] | |
PANTHER Pathway | 5HT2 type receptor mediated signaling pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.